We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Phase III Superiority Study of Vernakalant vs Amiodarone in Subjects With Recent Onset Atrial Fibrillation (AVRO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00668759
Recruitment Status : Completed
First Posted : April 29, 2008
Last Update Posted : December 15, 2009
Information provided by:
Cardiome Pharma

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : October 2009
  Study Completion Date : November 2009